Reaction #155336

Reaction equation

1-(2-Methoxyethyl)piperazine

triethylamine

2-Chloro-N-{3-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxy-4H-quinolin-1-yl]propyl}acetamide

→

N-{3-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxy-4H-quinolin-1-yl]propyl}-2-[4-(2-methoxyethyl)piperazin-1-yl]acetamide hydrochloride

Yield 41.3%

Solvents

acetonitrile

acetonitrile

Conditions

Workup

1. 1
   ConcentrationThe resulting mixture was concentrated under reduced pressure
2. 2
   Extractionthe residue was subjected to extraction
3. 3
   WashThe extract was then sequentially washed with water
4. 4
   ConcentrationThe washed product was concentrated under reduced pressure
5. 5
   Otherthe residue was purified
6. 6
   ConcentrationThe purified product was concentrated under reduced pressure
7. 7
   workup.DISSOLUTIONthe residue was then dissolved in ethyl acetate (5 ml)
8. 8
   workup.ADDITIONA 4N hydrogen chloride ethyl acetate solution (0.19 ml) was added
9. 9
   workup.STIRRINGstirred
10. 10
    Concentrationthe mixture was concentrated to dryness under reduced pressure

Procedure

2-Chloro-N-{3-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxy-4H-quinolin-1-yl]propyl}acetamide (370 mg, 0.8 mmol) was suspended in acetonitrile (12 ml). 1-(2-Methoxyethyl)piperazine (138 mg, 0.96 mmol), triethylamine (162 mg, 1.6 mmol) and acetonitrile (2 ml) were added to the suspension, and stirred at 70 to 80° C. for 6 hours. The resulting mixture was concentrated under reduced pressure, and the residue was subjected to extraction using ethyl acetate. The extract was then sequentially washed with water, an aqueous saturated sodium chloride solution, and an aqueous saturated sodium bicarbonate solution. The washed product was concentrated under reduced pressure, and the residue was purified using silica gel column chromatography (dichloromethane:methanol=30:1→10:1). The purified product was concentrated under reduced pressure, and the residue was then dissolved in ethyl acetate (5 ml). A 4N hydrogen chloride ethyl acetate solution (0.19 ml) was added thereto and stirred, and then the mixture was concentrated to dryness under reduced pressure, giving a pale yellow amorphous solid of N-{3-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxy-4H-quinolin-1-yl]propyl}-2-[4-(2-methoxyethyl)piperazin-1-yl]acetamide hydrochloride (200 mg).

Source